Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (31)
Ririka FujimuraAyano AsadaMisato AizawaItsuro Kazama. (2022) Cetirizine more potently exerts mast cell-stabilizing property than diphenhydramine. Drug Discoveries & Therapeutics 16:5, pages 245-250.
Crossref
Crossref
Lidia H. Pulz, Yonara G. Cordeiro, Greice C. Huete, Karine G. Cadrobbi, Arina L. Rochetti, Pedro L. P. Xavier, Adriana Tomoko Nishiya, Silvio Henrique de Freitas, Heidge Fukumasu & Ricardo F. Strefezzi. (2021) Intercellular interactions between mast cells and stromal fibroblasts obtained from canine cutaneous mast cell tumours. Scientific Reports 11:1.
Crossref
Crossref
Itsuro Kazama. (2020) Stabilizing mast cells by commonly used drugs: a novel therapeutic target to relieve post-COVID syndrome?. Drug Discoveries & Therapeutics 14:5, pages 259-261.
Crossref
Crossref
Asuka Baba, Masahiro Tachi, Yutaka Ejima, Yasuhiro Endo, Hiroaki Toyama, Kazutomo Saito, Nozomu Abe, Masanori Yamauchi, Chieko Miura & Itsuro Kazama. (2017) Less contribution of mast cells to the progression of renal fibrosis in Rat kidneys with chronic renal failure. Nephrology 22:2, pages 159-167.
Crossref
Crossref
Itsuro Kazama, Asuka Baba, Yasuhiro Endo, Hiroaki Toyama, Yutaka Ejima, Mitsunobu Matsubara & Masahiro Tachi. (2015) Mast cell involvement in the progression of peritoneal fibrosis in rats with chronic renal failure. Nephrology 20:9, pages 609-616.
Crossref
Crossref
Michael J. MonumentDavid A. HartPaul T. SaloA. Dean BefusKevin A. Hildebrand. (2015) Neuroinflammatory Mechanisms of Connective Tissue Fibrosis: Targeting Neurogenic and Mast Cell Contributions. Advances in Wound Care 4:3, pages 137-151.
Crossref
Crossref
Michael J. Monument, David A. Hart, Paul T. Salo, Kevin A. Hildebrand & A. Dean Befus. (2013) Posttraumatic elbow contractures: targeting neuroinflammatory fibrogenic mechanisms. Journal of Orthopaedic Science 18:6, pages 869-877.
Crossref
Crossref
Michael J Monument, David A Hart, A Dean Befus, Paul T Salo, Mei Zhang & Kevin A Hildebrand. (2010) The Mast Cell Stabilizer Ketotifen Fumarate Lessens Contracture Severity and Myofibroblast Hyperplasia. The Journal of Bone and Joint Surgery-American Volume 92:6, pages 1468-1477.
Crossref
Crossref
Glalcyara Lan?oni, Roberto Cuan Ravinal, Roberto Silva Costa & Ana Maria Roselino. (2008) Mast cells and transforming growth factor-? expression: a possible relationship in the development of porphyria cutanea tarda skin lesions. International Journal of Dermatology 47:6, pages 575-581.
Crossref
Crossref
Daniel Navi, Jun Saegusa & Fu-Tong Liu. (2007) Mast Cells and Immunological Skin Diseases. Clinical Reviews in Allergy & Immunology 33:1-2, pages 144-155.
Crossref
Crossref
Nobuyuki Harunari, Kathy Q. Zhu, Rebecca T. Armendariz, Heike Deubner, Pornprom Muangman, Gretchen J. Carrougher, F. Frank Isik, Nicole S. Gibran & Loren H. Engrav. (2006) Histology of the thick scar on the female, red Duroc pig: Final similarities to human hypertrophic scar. Burns 32:6, pages 669-677.
Crossref
Crossref
David A. Hart, Cyril B. Frank, Alison Kydd, Tyler Ivie, Paul Sciore & Carol Reno. 2005. Tendon Injuries. Tendon Injuries
40
48
.
Barry L. Gruber, Mary J. Marchese, Frances Santiago-Schwarz, Carla A. Martin, Jianhua Zhang & Richard R. Kew. (2004) Protease-Activated Receptor-2 (PAR-2) Expression in Human Fibroblasts is Regulated by Growth Factors and Extracellular Matrix. Journal of Investigative Dermatology 123:5, pages 832-839.
Crossref
Crossref
Toshiyuki Yamamoto. 2003. Animal Models of Human Inflammatory Skin Diseases. Animal Models of Human Inflammatory Skin Diseases
535
547
.
. (2003) Viewpoint 4. Experimental Dermatology 12:6, pages 897-898.
Crossref
Crossref
Toshiyuki Yamamoto & Kiyoshi Nishioka. (2003) Role of Monocyte Chemoattractant Protein-1 and its Receptor,CCR-2, in the Pathogenesis of Bleomycin-Induced Scleroderma. Journal of Investigative Dermatology 121:3, pages 510-516.
Crossref
Crossref
Junru Wang & Martin Hauer-Jensen. (2003) Radiation toxicity and proteinase-activated receptors. Drug Development Research 60:1, pages 1-8.
Crossref
Crossref
E. Crivellato, N. Finato, M. Isola, D. Ribatti & C. A. Beltrami. (2003) Low mast cell density in the human duodenal mucosa from chronic inflammatory duodenal bowel disorders is associated with defective villous architecture. European Journal of Clinical Investigation 33:7, pages 601-610.
Crossref
Crossref
P. M. Lackie & R. C. Benyon. (2003) What can be learned about the fibrosis of asthma from rodent models?. Clinical & Experimental Allergy 33:5, pages 546-549.
Crossref
Crossref
Barry L. Gruber. (2003) Mast cells in the pathogenesis of fibrosis. Current Rheumatology Reports 5:2, pages 147-153.
Crossref
Crossref
Motohiro Kurosawa, Akira Okano, Masatoshi Abe, Osamu Ishikawa, Naotomo Kanbe & Yoshiki Miyachi. 2003. Cardiomyopathies and Heart Failure. Cardiomyopathies and Heart Failure
133
144
.
Toshiyuki Yamamoto. (2002) Animal Model of Sclerotic Skin Induced by Bleomycin: A Clue to the Pathogenesis of and Therapy for Scleroderma?. Clinical Immunology 102:3, pages 209-216.
Crossref
Crossref
Toshiyuki Yamamoto, Karin Hartmann, Beate Eckes & Thomas Krieg. (2001) Role of stem cell factor and monocyte chemoattractant protein-1 in the interaction between fibroblasts and mast cells in fibrosis. Journal of Dermatological Science 26:2, pages 106-111.
Crossref
Crossref
Masatoshi Abe, Motohiro Kurosawa, Yasushi Igarashi, Osamu Ishikawa & Yoshiki Miyachi. (2000) Influence of IgE-mediated activation of cultured human mast cells on proliferation and type I collagen production by human dermal fibroblasts. Journal of Allergy and Clinical Immunology 106:1, pages S72-S77.
Crossref
Crossref
Nicholas W. Lukacs, Sandra H.P. Oliveira & Cory M. Hogaboam. 2000. Mast Cells and Basophils. Mast Cells and Basophils
609
621
.
Stephan C. Bischoff. 2000. Mast Cells and Basophils. Mast Cells and Basophils
541
565
.
Jianhua Zhang, Barry L. Gruber, Mary J. Marchese, Stanley Zucker, Lawrence B. Schwartz & Richard R. Kew. (1999) Mast cell tryptase does not alter matrix metalloproteinase expression in human dermal fibroblasts: Further evidence that proteolytically-active tryptase is a potent fibrogenic factor. Journal of Cellular Physiology 181:2, pages 312-318.
Crossref
Crossref
Michael A. McCloskey, Yihong Fan & Stacie Luther. (1999) Chemotaxis of Rat Mast Cells Toward Adenine Nucleotides. The Journal of Immunology 163:2, pages 970-977.
Crossref
Crossref
Bin Liu & M. Kari Connolly. (1998) The pathogenesis of cutaneous fibrosis. Seminars in Cutaneous Medicine and Surgery 17:1, pages 3-11.
Crossref
Crossref
Huda A. Makhluf, Joanna Stepniakowska, Stanley Hoffman, Edwin Smith, E. Carwile LeRoy & Maria Trojanowska. (1996) IL-4 Upregulates Tenascin Synthesis in Scleroderma and Healthy Skin Fibroblasts. Journal of Investigative Dermatology 107:6, pages 856-859.
Crossref
Crossref
E. Carwile LeRoy. (1996) SYSTEMIC SCLEROSIS. Rheumatic Disease Clinics of North America 22:4, pages 675-694.
Crossref
Crossref